ProQR Therapeutics N.V. buy StockNews.com
Start price
12.03.24
/
50%
€1.81
Target price
12.03.25
-
Performance (%)
-2.26%
Price
23.04.24
€1.89
Summary
This prediction is currently active. With a performance of -2.26%, the BUY prediction by StockNews_com is trending in the wrong direction. This prediction currently runs until 12.03.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | 2.547% | 2.547% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by StockNews_com for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by StockNews_com for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.25
11.11.23
11.11.23
-
11.11.24
11.11.24
45.20%
23.04.24
23.04.24
